Radiation therapy for young women with early breast cancer: Current state of the art
- PMID: 31014510
- DOI: 10.1016/j.critrevonc.2019.02.014
Radiation therapy for young women with early breast cancer: Current state of the art
Abstract
A diagnosis of breast cancer at a young age, defined per guidelines as ≤ 40 years, represents a challenging situation requiring additional attention by the treating physicians including radiation oncologists and surgeons involved in the local treatment of these tumors. The present review aims at providing updated evidence on the state of the art about the available techniques and indications for radiation therapy in patients with early breast cancer, specifically focusing on young women. In addition, future perspectives including the ongoing trials and the potential impact of combined approaches with systemic therapies (such as immunotherapy) are reviewed. Major conclusions from this overview are that young women affected by invasive breast cancer seem to receive the greatest benefit from the boost on the tumor bed. Most young patients affected by ductal carcinoma in situ should receive postoperative whole breast irradiation (WBI). When regional node irradiation is considered, young age should be considered as a high-risk factor. Partial breast irradiation is not suitable for young patients and should be recommended within the context of a clinical trial. Importantly, robust data have already supported the efficacy and safety of hypofractionated-WBI schedules that should now replace standard fractionated-WBI as gold standard for all patients irrespective of their age. Finally, organs-at-risk sparing systems as strategy for prevention of radiation-related long-term toxicities should be strongly considered for these patients. Considering the lack of inclusion of young patients in several published trials as well as in some of the ongoing ones, robust evidence to counsel young breast cancer patients on the optimal radiation therapy approach is still lacking. Further studies and ad hoc subgroup analyses in this specific patient population are strongly warranted.
Keywords: Hypofractionated-whole breast irradiation; Partial breast irradiation; Radiation therapy; Regional node irradiation; Tumor bed boost; Young patients.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Hypofractionated radiation treatment in the management of breast cancer.Expert Rev Anticancer Ther. 2018 Aug;18(8):793-803. doi: 10.1080/14737140.2018.1489245. Epub 2018 Jun 26. Expert Rev Anticancer Ther. 2018. PMID: 29902386 Free PMC article. Review.
-
Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.JAMA Oncol. 2015 Oct;1(7):931-41. doi: 10.1001/jamaoncol.2015.2666. JAMA Oncol. 2015. PMID: 26247543 Free PMC article. Clinical Trial.
-
Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.Cancer Prev Control. 1997 Aug;1(3):228-40. Cancer Prev Control. 1997. PMID: 9765748
-
Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.J Natl Cancer Inst. 2017 Nov 1;109(11). doi: 10.1093/jnci/djx068. J Natl Cancer Inst. 2017. PMID: 29059428
-
Abbreviated course of radiotherapy (RT) for breast cancer.Breast. 2011 Oct;20 Suppl 3:S116-27. doi: 10.1016/S0960-9776(11)70308-3. Breast. 2011. PMID: 22015277 Review.
Cited by
-
Increase in Hypofractionated Radiation Therapy Among Patients with Invasive Breast Cancer or Ductal Carcinoma In Situ: Who is Left Behind?Pract Radiat Oncol. 2024 Sep-Oct;14(5):e305-e323. doi: 10.1016/j.prro.2024.04.010. Epub 2024 Apr 27. Pract Radiat Oncol. 2024. PMID: 38685449
-
Predicting Radiation Esophagitis in Patients Undergoing Synchronous Boost Radiotherapy Post-Breast-Conserving Surgery.Dose Response. 2025 Apr 15;23(2):15593258251335802. doi: 10.1177/15593258251335802. eCollection 2025 Apr-Jun. Dose Response. 2025. PMID: 40297669 Free PMC article.
-
Evidence-based guidelines for hypofractionated radiation in breast cancer: conclusions of the Catalan expert working group.Clin Transl Oncol. 2022 Aug;24(8):1580-1587. doi: 10.1007/s12094-022-02798-8. Epub 2022 Feb 21. Clin Transl Oncol. 2022. PMID: 35190961 Free PMC article.
-
Comparing Hypofractionated With Conventional Fractionated Radiotherapy After Breast-Conserving Surgery for Early Breast Cancer: A Meta-Analysis of Randomized Controlled Trials.Front Oncol. 2021 Oct 1;11:753209. doi: 10.3389/fonc.2021.753209. eCollection 2021. Front Oncol. 2021. PMID: 34660318 Free PMC article.
-
The Prognoses of Young Women With Breast Cancer (≤35 years) With Different Surgical Options: A Propensity Score Matching Retrospective Cohort Study.Front Oncol. 2022 Feb 28;12:795023. doi: 10.3389/fonc.2022.795023. eCollection 2022. Front Oncol. 2022. PMID: 35296009 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical